Form 4: AtriCure CEO Acquires Shares Under ESPP
Insider Transaction Report
AtriCure, Inc. CEO Michael H. Carrel acquired company shares through the Employee Stock Purchase Plan on June 30, 2026.
Summary
- Michael H. Carrel, President, CEO, and Director of AtriCure, Inc., acquired 636 shares of common stock on June 30, 2026.
- These shares were purchased through the AtriCure, Inc. 2018 Employee Stock Purchase Plan (ESPP).
- The purchase price was $23.78 per share, representing 85% of the closing price on June 30, 2026, which was $27.98.
- Following this transaction, Carrel beneficially owns 779,134 shares directly.
- Additionally, he has indirect beneficial ownership of shares held by his children, parents, and sibling, though he disclaims beneficial ownership except for his pecuniary interest.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine transaction by an executive under an existing employee stock purchase plan, rather than a significant strategic event.
Positives
- CEO's participation in the ESPP indicates confidence in the company's stock.
- Acquisition of shares at a discount through the ESPP is a benefit for the executive.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which details a stock transaction.
Industry Context
StockSavvy.ai notes that insider transactions, such as this ESPP purchase by the CEO, are common within the medical device industry as a way for executives to align their interests with shareholders and benefit from company stock programs.
Stakeholder Impact
- Shareholders: The transaction may be viewed positively as the CEO is investing further in the company, but it is a standard ESPP purchase and not a large discretionary buy.
- Employees: Participation in the ESPP is a benefit offered to employees, including executives, to acquire company stock.
- Management: The CEO continues to hold a significant number of shares, aligning personal wealth with company performance.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Transaction Date for share acquisition under ESPP and last trading day of the offering period. |
| 07/02/2026 | Date of signature for the Form 4 filing. |
Keywords
AtriCure, ATRC, Form 4, Insider Trading, Employee Stock Purchase Plan, ESPP, Stock Acquisition, CEO, Michael H. Carrel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.